Videos & Interviews

Monsanto Trials: Oncologist's eye-opening testimony: Dr Chadi Nabhan Part 1

Gut Health Gurus

7/31/23

Dr Chadi Nabhan, MD, is an oncologist who has been involved in litigation cases with Monsanto. In this video, we explore his background in oncology.

Chadi Nabhan, MD, MBA, FACP, Discusses Highlights from The HemOnc Pulse at ASCO

Blood Cancers Society

6/14/23

Chadi Nabhan, MD, MBA, FACP, host of The HemOnc Pulse, discusses key highlights from The HemOnc Pulse during the 2023 American Society of Clinical Oncology Annual Meeting.

Author Chadi Nabhan, MD, MBA, FACP, on the Story Behind 'Toxic Exposure'

Blood Cancers Todat

6/14/23

Author Chadi Nabhan, MD, MBA, FACP, discusses the experiences that led him to write his new book, "Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice."

The HemOnc Pulse Live at ASH: Robert Orlowski, MD, PhD, on Bispecifics, MRD in Myeloma

Blood Cancers Today

12/20/22

Robert Orlowski, MD, PhD, of the University of Texas MD Anderson Cancer Center, discusses advances in myeloma treatment with Chadi Nabhan, MD, MBA, FACP, during the 2022 ASH Annual Meeting. Dr. Orlowski and Dr. Nabhan discussed bispecific antibodies, novel targets, the role of minimal residual disease in clinical practice, and more.

Chadi Nabhan: good medicine, death, shame, science, public health | #7 | The Graft Podcast

EBMP Traiinees

7/12/21

A conversation with Chadi Nabhan (@chadinabhan), Chairman of Precision Oncology Alliance at Caris Life Sciences. We talk with him about good medicine, the art of being human, actually caring for patients, and the essence of science and its abuse in current times of COVID. With his podcast healthcare unfiltered, his perspective articles in Journal of Clinical Oncology, JAMA and others, he is a really human voice in an ever challenging environment of pretenders.

Dr. Chadi Nabhan (Pt 1): Reviewing a Medical Career Path from Clinic to the Business of Health Care

BeaconMedIC

6/19/19

Dr. Chadi Nabhan speaks with host Jack West & reviews his circuitous course from medical training in Syria to lymphoma specialist & rising administrator in Chicago to his decision to pursue an MBA, leading him into a world of the business of health care.

Chadi Nabhan, MD, MBA, elaborates on the skepticism regarding MACRA

OBRoncology

12/6/18

Dr. Nabhan, VP, Chief Medical Officer, Cardinal Health Specialty Solutions, considers why oncologists remain skeptical about the overall benefits of MACRA.

The future of biosimilars in cancer treatments

AtlanticLIVE

6/5/18

As patents for biologics emerge on the marketplace, what will be their role within the cancer community? Will biosimilars provide alternatives for cancer treatment? In addition to alternatives, what information and education is needed for stakeholders to make informed choices about the cancer treatments? Gary Lyman of Fred Hutchinson Cancer Research and Chadi Nabhan of Cardinal Health Specialty Solutions join Steve Clemons onstage to discuss.

MACRA – What healthcare executives need to know

Cardinal Health

2/15/17

Dr. Chadi Nabhan, Chief Medical Officer of Cardinal Health Specialty Solutions, describes what healthcare executives at hospitals and health systems need to know about Medicare Access and Chip Reauthorization Act (MACRA). Signed into law in 2015, the act modifies the physicians Medicare payment schedule so that care delivery is focused on quality and on making patients healthier.